BCRX logo

BioCryst Pharmaceuticals (BCRX) Gross profit

Annual gross profit:

$438.23M+$111.48M(+34.12%)
December 31, 2024

Summary

  • As of today (May 29, 2025), BCRX annual gross profit is $438.23 million, with the most recent change of +$111.48 million (+34.12%) on December 31, 2024.
  • During the last 3 years, BCRX annual gross profit has risen by +$288.32 million (+192.33%).
  • BCRX annual gross profit is now at all-time high.

Performance

BCRX Gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXincome statement metrics

quarterly gross profit:

$140.97M+$15.56M(+12.41%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BCRX quarterly gross profit is $140.97 million, with the most recent change of +$15.56 million (+12.41%) on March 31, 2025.
  • Over the past year, BCRX quarterly gross profit has increased by +$49.47 million (+54.07%).
  • BCRX quarterly gross profit is now at all-time high.

Performance

BCRX quarterly gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXincome statement metrics

TTM gross profit:

$487.82M+$49.47M(+11.29%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BCRX TTM gross profit is $487.82 million, with the most recent change of +$49.47 million (+11.29%) on March 31, 2025.
  • Over the past year, BCRX TTM gross profit has increased by +$137.42 million (+39.22%).
  • BCRX TTM gross profit is now at all-time high.

Performance

BCRX TTM gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXincome statement metrics

Gross profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

BCRX Gross profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+34.1%+54.1%+39.2%
3 y3 years+192.3%+183.7%+161.7%
5 y5 years+879.6%+2865.2%+982.0%

BCRX Gross profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+192.3%at high+183.7%at high+161.7%
5 y5-yearat high+2615.8%at high+4810.0%at high+2923.2%
alltimeall timeat high+7056.0%at high+2173.0%at high+7968.1%

BCRX Gross profit History

DateAnnualQuarterlyTTM
Mar 2025
-
$140.97M(+12.4%)
$487.82M(+11.3%)
Dec 2024
$438.23M(+34.1%)
$125.40M(+10.1%)
$438.35M(+8.3%)
Sep 2024
-
$113.86M(+5.8%)
$404.71M(+7.5%)
Jun 2024
-
$107.60M(+17.6%)
$376.46M(+7.4%)
Mar 2024
-
$91.50M(-0.3%)
$350.41M(+7.2%)
Dec 2023
$326.75M(+23.7%)
$91.76M(+7.2%)
$326.75M(+4.7%)
Sep 2023
-
$85.61M(+5.0%)
$312.04M(+4.5%)
Jun 2023
-
$81.54M(+20.2%)
$298.64M(+5.8%)
Mar 2023
-
$67.84M(-12.0%)
$282.39M(+6.9%)
Dec 2022
$264.23M(+76.3%)
$77.05M(+6.7%)
$264.23M(+13.0%)
Sep 2022
-
$72.21M(+10.6%)
$233.92M(+15.8%)
Jun 2022
-
$65.28M(+31.4%)
$202.09M(+8.4%)
Mar 2022
-
$49.69M(+6.3%)
$186.42M(+24.4%)
Dec 2021
$149.91M(+829.0%)
$46.74M(+15.8%)
$149.87M(+40.0%)
Sep 2021
-
$40.38M(-18.6%)
$107.07M(+50.2%)
Jun 2021
-
$49.62M(+277.7%)
$71.26M(+190.7%)
Mar 2021
-
$13.14M(+233.8%)
$24.52M(+51.9%)
Dec 2020
$16.14M(-63.9%)
$3.94M(-14.0%)
$16.14M(-67.3%)
Sep 2020
-
$4.58M(+59.4%)
$49.35M(+6.1%)
Jun 2020
-
$2.87M(-39.6%)
$46.54M(+3.2%)
Mar 2020
-
$4.75M(-87.2%)
$45.09M(+0.8%)
Dec 2019
$44.73M(+121.7%)
$37.15M(+2014.6%)
$44.73M(+336.9%)
Sep 2019
-
$1.76M(+23.6%)
$10.24M(+3.2%)
Jun 2019
-
$1.42M(-67.7%)
$9.92M(-52.2%)
Mar 2019
-
$4.40M(+65.5%)
$20.75M(+2.8%)
Dec 2018
$20.18M(-14.1%)
$2.66M(+85.2%)
$20.18M(-5.2%)
Sep 2018
-
$1.44M(-88.3%)
$21.28M(-22.2%)
Jun 2018
-
$12.25M(+219.4%)
$27.35M(+50.5%)
Mar 2018
-
$3.84M(+2.0%)
$18.18M(-22.6%)
Dec 2017
$23.48M(-0.7%)
$3.76M(-49.9%)
$23.48M(-10.6%)
Sep 2017
-
$7.50M(+143.8%)
$26.25M(-0.4%)
Jun 2017
-
$3.08M(-66.3%)
$26.37M(-6.0%)
Mar 2017
-
$9.14M(+40.0%)
$28.05M(+18.6%)
Dec 2016
$23.65M(-49.0%)
$6.53M(-14.3%)
$23.65M(+9.0%)
Sep 2016
-
$7.62M(+60.1%)
$21.70M(-8.5%)
Jun 2016
-
$4.76M(+0.4%)
$23.71M(-46.5%)
Mar 2016
-
$4.74M(+3.7%)
$44.35M(-4.3%)
Dec 2015
$46.36M(+243.8%)
$4.57M(-52.5%)
$46.36M(-1.8%)
Sep 2015
-
$9.64M(-62.1%)
$47.19M(+15.7%)
Jun 2015
-
$25.40M(+276.2%)
$40.79M(+142.1%)
Mar 2015
-
$6.75M(+25.0%)
$16.85M(+25.0%)
Dec 2014
$13.49M(-21.7%)
$5.40M(+66.8%)
$13.49M(-27.6%)
Sep 2014
-
$3.24M(+121.6%)
$18.63M(+4.8%)
Jun 2014
-
$1.46M(-56.8%)
$17.79M(+3.8%)
Mar 2014
-
$3.38M(-67.9%)
$17.14M(-0.5%)
DateAnnualQuarterlyTTM
Dec 2013
$17.23M(-34.1%)
$10.55M(+341.6%)
$17.23M(+60.1%)
Sep 2013
-
$2.39M(+192.4%)
$10.77M(-23.2%)
Jun 2013
-
$817.00K(-76.5%)
$14.02M(-19.5%)
Mar 2013
-
$3.48M(-14.8%)
$17.42M(-33.4%)
Dec 2012
$26.16M(+33.2%)
$4.08M(-27.7%)
$26.16M(-4.2%)
Sep 2012
-
$5.65M(+34.1%)
$27.30M(+1.5%)
Jun 2012
-
$4.21M(-65.6%)
$26.90M(+1.8%)
Mar 2012
-
$12.22M(+133.9%)
$26.43M(+34.5%)
Dec 2011
$19.64M(-68.5%)
$5.22M(-0.5%)
$19.64M(-36.9%)
Sep 2011
-
$5.25M(+40.5%)
$31.11M(-17.8%)
Jun 2011
-
$3.73M(-31.3%)
$37.86M(-9.3%)
Mar 2011
-
$5.43M(-67.4%)
$41.74M(-33.0%)
Dec 2010
$62.30M(-11.1%)
$16.69M(+39.1%)
$62.30M(-35.1%)
Sep 2010
-
$12.00M(+57.6%)
$95.95M(+1.5%)
Jun 2010
-
$7.62M(-70.7%)
$94.50M(+3.1%)
Mar 2010
-
$25.98M(-48.4%)
$91.67M(+30.9%)
Dec 2009
$70.05M(+23.8%)
$50.35M(+377.4%)
$70.05M(+255.7%)
Sep 2009
-
$10.55M(+120.3%)
$19.69M(+115.3%)
Jun 2009
-
$4.79M(+9.8%)
$9.15M(+109.8%)
Mar 2009
-
$4.36M(+506.3%)
$4.36M(+31.6%)
Dec 2008
$56.56M(+1785.4%)
-
-
Mar 2000
-
$719.00K(+619.0%)
$3.31M(+3.7%)
Dec 1999
$3.00M(-56.5%)
$100.00K(-1.0%)
$3.19M(-11.1%)
Sep 1999
-
$101.00K(-95.8%)
$3.59M(-62.5%)
Jun 1999
-
$2.39M(+298.7%)
$9.59M(+26.2%)
Mar 1999
-
$600.00K(+20.0%)
$7.60M(+5.6%)
Dec 1998
$6.90M(+331.3%)
$500.00K(-91.8%)
$7.20M(+5.9%)
Sep 1998
-
$6.10M(+1425.0%)
$6.80M(+580.0%)
Jun 1998
-
$400.00K(+100.0%)
$1.00M(-44.4%)
Mar 1998
-
$200.00K(+100.0%)
$1.80M(-263.6%)
Dec 1997
$1.60M(-23.8%)
$100.00K(-66.7%)
-$1.10M(-35.3%)
Sep 1997
-
$300.00K(-75.0%)
-$1.70M(+6.3%)
Jun 1997
-
$1.20M(-144.4%)
-$1.60M(+77.8%)
Mar 1997
-
-$2.70M(+440.0%)
-$900.00K(-145.0%)
Dec 1996
$2.10M(-133.3%)
-$500.00K(-225.0%)
$2.00M(-146.5%)
Sep 1996
-
$400.00K(-78.9%)
-$4.30M(-4.4%)
Jun 1996
-
$1.90M(+850.0%)
-$4.50M(-27.4%)
Mar 1996
-
$200.00K(-102.9%)
-$6.20M(+3.3%)
Dec 1995
-$6.30M(+46.5%)
-$6.80M(-3500.0%)
-$6.00M(+900.0%)
Sep 1995
-
$200.00K(0.0%)
-$600.00K(-68.4%)
Jun 1995
-
$200.00K(-50.0%)
-$1.90M(-40.6%)
Mar 1995
-
$400.00K(-128.6%)
-$3.20M(-27.3%)
Dec 1994
-$4.30M
-$1.40M(+27.3%)
-$4.40M(+46.7%)
Sep 1994
-
-$1.10M(0.0%)
-$3.00M(+57.9%)
Jun 1994
-
-$1.10M(+37.5%)
-$1.90M(+137.5%)
Mar 1994
-
-$800.00K
-$800.00K

FAQ

  • What is BioCryst Pharmaceuticals annual gross profit?
  • What is the all time high annual gross profit for BioCryst Pharmaceuticals?
  • What is BioCryst Pharmaceuticals annual gross profit year-on-year change?
  • What is BioCryst Pharmaceuticals quarterly gross profit?
  • What is the all time high quarterly gross profit for BioCryst Pharmaceuticals?
  • What is BioCryst Pharmaceuticals quarterly gross profit year-on-year change?
  • What is BioCryst Pharmaceuticals TTM gross profit?
  • What is the all time high TTM gross profit for BioCryst Pharmaceuticals?
  • What is BioCryst Pharmaceuticals TTM gross profit year-on-year change?

What is BioCryst Pharmaceuticals annual gross profit?

The current annual gross profit of BCRX is $438.23M

What is the all time high annual gross profit for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals all-time high annual gross profit is $438.23M

What is BioCryst Pharmaceuticals annual gross profit year-on-year change?

Over the past year, BCRX annual gross profit has changed by +$111.48M (+34.12%)

What is BioCryst Pharmaceuticals quarterly gross profit?

The current quarterly gross profit of BCRX is $140.97M

What is the all time high quarterly gross profit for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals all-time high quarterly gross profit is $140.97M

What is BioCryst Pharmaceuticals quarterly gross profit year-on-year change?

Over the past year, BCRX quarterly gross profit has changed by +$49.47M (+54.07%)

What is BioCryst Pharmaceuticals TTM gross profit?

The current TTM gross profit of BCRX is $487.82M

What is the all time high TTM gross profit for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals all-time high TTM gross profit is $487.82M

What is BioCryst Pharmaceuticals TTM gross profit year-on-year change?

Over the past year, BCRX TTM gross profit has changed by +$137.42M (+39.22%)
On this page